Compounding Pharmacy · Est. 2020 · Charlotte, NC · Both
Revelation Pharma Review
Revelation Pharma is a growing network of 503A and 503B compounding pharmacies headquartered in Charlotte, North Carolina. The network has acquired multiple regional compounding pharmacies and supplies sterile compounds. Its published weight-management ingredient list does not include semaglutide or tirzepatide.
Revelation's published weight-management ingredient list does not include semaglutide or tirzepatide, and which GLP-1s can still be compounded explains the current federal rules on those two drugs. One regional pharmacy it acquired, Innovation Compounding in Kennesaw, Georgia, does list both.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Top-Rated GLP-1 Partners
Not sourced from Revelation Pharma — these are our highest-scored vetted GLP-1 telehealth partners, if you'd rather start with a provider we've walked through end to end.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
No insurance needed · HSA/FSA eligible · vetted by our editors
Ro
FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Starting price: $149/mo (+ required membership)
Get started →Read review Ro →Collective
The lowest flat medication price if you can absorb an annual membership fee
Starting price: $59/mo (+ required membership)
Get started →Read review Collective →CoreAge Rx
Lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Starting price: $79/mo (“starting at” price)
Get started →Read review CoreAge Rx →Embody
Low flat-rate compounded GLP-1 pricing at every dose
Starting price: $79/mo (sale price)
Get started →Read review Embody →| Provider | Starting price | |
|---|---|---|
7.7Ro | $149/mo (+ required membership) | Get started → |
8.3Collective | $59/mo (+ required membership) | Get started → |
8.3CoreAge Rx | $79/mo (“starting at” price) | Get started → |
7.8Embody | $79/mo (sale price) | Get started → |
Certifications & Compliance
All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.
Drugs Produced
States Licensed
Revelation Pharma has not published a state-by-state licensure list. Verify licensure for your state directly with your state board of pharmacy before filling a prescription here.
Regulatory Actions
External Reviews
Weight Loss Rankings Score Breakdown
Scores are independently researched. See our methodology for details.
Low confidence · Pharmacy details last verified November 2026 · How we verify provider data
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources & methodology (as of November 2026)
- 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
- 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
- 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
- 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.